Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2022-11-11 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
关于使用部分闲置募集资金进行现金管理的进展公告（一）
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. regarding the progress of using part of idle raised funds for cash management, specifically purchasing a structured deposit product from China Construction Bank. It details the investment product, risk control measures, and cumulative usage of idle raised funds. The document is relatively short (1543 characters) and focuses on a financing activity update related to the use of raised funds, not a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-11-11 Chinese
关于完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration changes and issuance of a new business license by Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It details changes in registered capital and company type, referencing a prior announcement for more details. The document is short (738 characters) and serves as a formal notification of corporate registration updates rather than a financial report or detailed filing. It does not contain financial statements, audit information, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-11-11 Chinese
深圳市美好创亿医疗科技股份有限公司关于签订募集资金四方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a four-party supervision agreement related to the management and use of funds raised from the company's initial public offering (IPO). It details the establishment of special accounts for the raised funds, the roles and responsibilities of involved parties, and regulatory compliance. The document does not contain financial statements or detailed financial performance data but rather focuses on the regulatory and procedural aspects of fund management. The length is relatively short (2618 characters), and it is an announcement about a regulatory agreement related to capital raising. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2022-11-09 Chinese
东兴证券股份有限公司关于深圳市美好创亿医疗科技股份有限公司使用募集资金置换预先投入募投项目自筹资金及已支付发行费用的自筹资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a verification opinion from Dongxing Securities regarding the use of raised funds by Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. to replace self-raised funds previously invested in projects and paid issuance expenses. It references regulatory guidelines, approvals from the board, supervisory board, independent directors, and an audit firm report. The document is focused on the verification and approval of the use of funds rather than presenting financial statements or results. It is a specialized audit or verification report related to fundraising and fund usage compliance, not a full annual or interim report, earnings release, or capital update. The document length is 3705 characters, which is relatively short but contains detailed verification and audit opinions. This fits best under Audit Report / Information (AR) as it is a standalone audit/verification report on the use of funds and compliance with regulations.
2022-11-03 Chinese
深圳市美好创亿医疗科技股份有限公司第一届监事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. It details the convening and voting results of the 12th meeting of the first Supervisory Board, including approval of a proposal regarding the use of raised funds. The document is an official announcement of a board meeting decision, not a full report or financial statement. It does not contain financial data or detailed management discussion, nor is it a regulatory certification or voting result announcement at a shareholder meeting. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies.
2022-11-03 Chinese
深圳市美好创亿医疗科技股份有限公司第一届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 16th meeting of the first board of directors of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It includes details about the meeting's convening, attendance, and voting results on specific proposals. There is no financial data, no detailed report content, and no indication that this is a full annual or interim report. The document is clearly about board meeting decisions and related disclosures. Therefore, it fits best under 'Board/Management Information' (MANG), which covers announcements of changes or decisions by the board of directors.
2022-11-03 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.